If pharma looks slow to adopt AI, it’s got good reason, expert says

by Carly Helfand | May 1, 2019 11:04am | FiercePharma And just because pharma may be moving more slowly than other industries doesn’t mean it’s shying away. On the contrary, Harel said, CytoReason—which will present as part of the AI and Digital Health tracks next month at the MIXiii BIOMED conference in Tel Aviv—has seen “most large […]